Why are we considering palmitoylethanolamide (PEA) for COVID19? We have been interested in this molecule for years and have used in our allergy patients (it has well-documented mast cell stabilizing properties), in our pain patients and as influenza treatment and prophylaxis. In this most recent COVID19 pandemic, I think PEA is worth considering, although we…
Immunologist and integrative health expert Heather Zwickey, PhD, shares excellent information in this podcast on COVID-19 and natural medicines. While there is no natural product research published specifically on COVID-19 yet, there is much underway. While we wait for those results to come in (they’ll be a while), Zwickey covers the current understanding of the…
I wanted to share this resource from the American Association of Naturopathic Physicians. … “As concerns about the spread of coronavirus mount and efforts to contain it escalate, Naturopathic Doctors should be aware of the latest advisories from public health agencies and credible organizations, and be prepared to report and/or advise patients accordingly. … The…
Dr. Manuel Salvadori, Functional Medicine physician in Italy, is addressing those with COVID19 in his practice using the following protocol. To quote him directly in response to me asking how his patients were faring with what he’s prescribing: “It’s not possible to evaluate results on the CoVID-19, as you can’t really tell if people are…
One good piece of news is that this virus is actually fairly helpless when it comes to hand sanitizers and old-fashioned soap. Coronaviruses are envelope viruses, meaning they have a coating that is easily disrupted with alcohol-based hand sanitizers and soaps (other viruses like norovirus and rhinovirus are not, and require serious hand washing to…
Promising pharmaceutical treatment (a repurposed flu drug) for early-stage COVID-19 could be available as early as May. Testing in 340 patients in Japan appears to reduce the median duration of infection from 11 to 4 days. 91% of those treated showed improved lung condition compared to 62% without treatment. Early intervention may be key as…
Today, my goal is to bang out what *I think* may be critical botanical and nutraceutical interventions for COVID19 (SARS Cov2) prevention and treatment.
The gut is a major site for IgE-producing B cells in peanut-allergic patients, defined for the first time by new research. The authors also found evidence suggesting that isotype switching can occur in GI tissue – including switching from IgA and IgG to IgE immunoglobulin types. This new understanding presents opportunities for future interventions to…
Can we describe experiences as becoming extinct? How many of us are lacking the following: time spent in nature, and contact with biodiverse environments and microbes? Children especially, occupied by homework and screens, can miss out. Jeff Bland and Susan Prescott coauthored this new peer-reviewed paper that paints an expansive and remarkable view of the…
We are all familiar with the Wahls Protocol. But how about the story behind the protocol? Did you know, for instance, that her director at U of Iowa (Terry is a clinician-researcher) told her to write up herself as a case report? That was the first step. Her “N of 1”; then she wrote up a case series. Then she received a small grant and product for a slightly larger study. Then a million dollars. And now she’s heading into her largest study to date (yes, you will be able to refer patients). Listen to our New Frontiers conversation on how YOU as a FxMed clinician can contribute to the body of research demonstrating that: What. We. Do. Works.